SARomics Biostructures AB
Protein Crystallography & Integrated Drug Discovery: Fragment Screening & Fragment-Based Drug Design
Protein Crystallography & Integrated Drug Discovery: Fragment Screening & Fragment-Based Drug Design
SARomics Biostructures AB: SARomics Biostructures AB, founded in 2006 and headquartered in Sweden, specializes in offering an array of structural biology and drug discovery services. Their expertise includes X-ray crystallography and protein NMR spectroscopy, along with fragment screening and structure-based drug design services. The company's capabilities comprise protein cloning, expression, crystallization, fragment screening, and higher-order structure analysis of biosimilars. Notably, SARomics Biostructures AB received a Venture Round investment on 08 September 2020 from LU Innovation.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 | LU Innovation | 08 Sep 2020 |
| Venture Round | Unknown | - | 06 Mar 2014 | |
| Venture Round | Unknown | 3 |
|
25 Oct 2012 |
No recent news or press coverage available for SARomics Biostructures AB.
We care about your data, and we'd love to use cookies make your experience better.
